Kathryn E. Stephenson

7.5k total citations · 1 hit paper
34 papers, 800 citations indexed

About

Kathryn E. Stephenson is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Kathryn E. Stephenson has authored 34 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Virology, 12 papers in Infectious Diseases and 10 papers in Immunology. Recurrent topics in Kathryn E. Stephenson's work include HIV Research and Treatment (18 papers), Immune Cell Function and Interaction (8 papers) and HIV/AIDS drug development and treatment (5 papers). Kathryn E. Stephenson is often cited by papers focused on HIV Research and Treatment (18 papers), Immune Cell Function and Interaction (8 papers) and HIV/AIDS drug development and treatment (5 papers). Kathryn E. Stephenson collaborates with scholars based in United States, United Kingdom and Belgium. Kathryn E. Stephenson's co-authors include Dan H. Barouch, Peter Abbink, Bette Korber, Kshitij Wagh, Matthieu Daniel, Lisa F. P. Ng, Koen Bartholomeeusen, Philippe Gasque, Rosanna Ŵ. Peeling and Kevin K. Ariën and has published in prestigious journals such as Nature Communications, PLoS ONE and Annual Review of Immunology.

In The Last Decade

Kathryn E. Stephenson

31 papers receiving 780 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chikungunya fever

2023 120 citations Koen Bartholomeeusen, Matthieu Daniel et al. Nature Reviews Disease Primers profile →

Peers

Kathryn E. Stephenson

VIROL

PHEOH

IMMUN

Wes Rountree United States

Claire M. Midgley United States

Leslie Goo United States

Jennifer M. Pfaff United States

Ingelise J. Gordon United States

M J McElrath United States

Li‐Hua Ping United States

Christopher A. Todd United States

Michel Janssens Belgium

Chasity D. Andrews United States

Wes Rountree United States

Kathryn E. Stephenson

424 ×1.1

303 ×0.8

VIROL

93 ×0.4

PHEOH

201 ×1.0

IMMUN

141 ×0.8

Citations per year, relative to Kathryn E. Stephenson Kathryn E. Stephenson (= 1×) peers Wes Rountree

Countries citing papers authored by Kathryn E. Stephenson

Since Specialization

Citations

This map shows the geographic impact of Kathryn E. Stephenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn E. Stephenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn E. Stephenson more than expected).

Fields of papers citing papers by Kathryn E. Stephenson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn E. Stephenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn E. Stephenson. The network helps show where Kathryn E. Stephenson may publish in the future.

Co-authorship network of co-authors of Kathryn E. Stephenson

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn E. Stephenson. A scholar is included among the top collaborators of Kathryn E. Stephenson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn E. Stephenson. Kathryn E. Stephenson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stephenson, Kathryn E.. (2025). Next-Generation Coronavirus Disease 2019 Vaccines. Infectious Disease Clinics of North America. 39(2). 253–274.

Vielot, Nadja A., Christina Ludema, Molly Rosenberg, et al.. (2024). Patterns and predictors of COVID-19 vaccination among young adults at 44 US sites: Secondary analysis of a randomized, controlled, open-label trial, March – December 2021. Vaccine. 42(23). 126237–126237.

Brock-Fisher, Taylor, Brittany A. Petros, Gage K. Moreno, et al.. (2024). Severe Acute Respiratory Syndrome Coronavirus 2 Household Transmission During the Omicron Era in Massachusetts: A Prospective, Case-Ascertained Study Using Genomic Epidemiology. Open Forum Infectious Diseases. 11(11). ofae591–ofae591.

Stephenson, Kathryn E., et al.. (2024). HIV Vaccine Development at a Crossroads: New B and T Cell Approaches. Vaccines. 12(9). 1043–1043. 5 indexed citations

Vanshylla, Kanika, Jeroen Tolboom, Kathryn E. Stephenson, et al.. (2024). Mosaic HIV-1 vaccine and SHIV challenge strain V2 loop sequence identity and protection in primates. npj Vaccines. 9(1). 179–179. 1 indexed citations

Aïd, Malika, Kathryn E. Stephenson, Ai‐ris Y. Collier, et al.. (2023). Activation of coagulation and proinflammatory pathways in thrombosis with thrombocytopenia syndrome and following COVID-19 vaccination. Nature Communications. 14(1). 6703–6703. 8 indexed citations

Bartholomeeusen, Koen, Matthieu Daniel, Philippe Gasque, et al.. (2023). Author Correction: Chikungunya fever. Nature Reviews Disease Primers. 9(1). 1 indexed citations

Yu, Xiaoying, Erin E. Sundermann, Darren J. Baker, et al.. (2022). Current Challenges and Solutions for Clinical Management and Care of People with HIV: Findings from the 12th Annual International HIV and Aging Workshop. AIDS Research and Human Retroviruses. 39(1). 1–12. 3 indexed citations

Marcelin, Jasmine R, Audrey Pettifor, Holly Janes, et al.. (2022). COVID-19 Vaccines and SARS-CoV-2 Transmission in the Era of New Variants: A Review and Perspective. Open Forum Infectious Diseases. 9(5). ofac124–ofac124. 26 indexed citations

10.

Anderson, Matthew P., et al.. (2022). Fatal Post COVID mRNA-Vaccine Associated Cerebral Ischemia. The Neurohospitalist. 13(2). 156–158. 1 indexed citations

11.

Abbink, Peter, Kathryn E. Stephenson, & Dan H. Barouch. (2018). Zika virus vaccines. Nature Reviews Microbiology. 16(10). 594–600. 79 indexed citations

12.

Stephenson, Kathryn E., Michael C. Keefer, Catherine A. Bunce, et al.. (2018). First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1. PLoS ONE. 13(11). e0205139–e0205139. 28 indexed citations

13.

Stephenson, Kathryn E.. (2018). Therapeutic vaccination for HIV. Current Opinion in HIV and AIDS. 13(5). 408–415. 25 indexed citations

14.

Larocca, Rafael A., Nicholas M. Provine, Malika Aïd, et al.. (2016). Adenovirus serotype 5 vaccine vectors trigger IL-27–dependent inhibitory CD4 ⁺ T cell responses that impair CD8 ⁺ T cell function. Science Immunology. 1(5). 16 indexed citations

15.

Stephenson, Kathryn E. & Dan H. Barouch. (2016). Broadly Neutralizing Antibodies for HIV Eradication. Current HIV/AIDS Reports. 13(1). 31–37. 70 indexed citations

16.

Stephenson, Kathryn E., George H. Neubauer, Christine A. Bricault, et al.. (2016). Antibody Responses After Analytic Treatment Interruption in Human Immunodeficiency Virus-1-Infected Individuals on Early Initiated Antiretroviral Therapy. Open Forum Infectious Diseases. 3(2). ofw100–ofw100. 14 indexed citations

17.

Stephenson, Kathryn E., George H. Neubauer, Ulf Reimer, et al.. (2014). Quantification of the epitope diversity of HIV-1-specific binding antibodies by peptide microarrays for global HIV-1 vaccine development. Journal of Immunological Methods. 416. 105–123. 28 indexed citations

18.

Stephenson, Kathryn E., John Hural, Susan Buchbinder, Faruk Sinangil, & Dan H. Barouch. (2012). Preexisting Adenovirus Seropositivity Is Not Associated With Increased HIV-1 Acquisition in Three HIV-1 Vaccine Efficacy Trials. The Journal of Infectious Diseases. 205(12). 1806–1810. 14 indexed citations

19.

Stephenson, Kathryn E.. (2004). Public Health Chronicles. Public Health Reports. 119(1). 79–92. 2 indexed citations

20.

Brosgart, Carol, et al.. (1999). Clinical Experience and Choice of Drug Therapy for Human Immunodeficiency Virus Disease. Clinical Infectious Diseases. 28(1). 14–22. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact